CLASS II Drug recall · Reported 17 Dec 2014 · FDA Enforcement Report

Cyanocobalamin Injection, USP, 1000 mcg/mL recalled

Fresenius Kabi USA is recalling Cyanocobalamin Injection, USP, 1000 mcg/mL, For IM or IV Use, Multiple Dose Vials, distributed nationwide in the US. The recall was initiated on 27 Sep 2012 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot 6003853, exp. date 04/2014
NDC63323-044
Quantity recalled240,550 Vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0297-2015
FDA event ID
63451
Recalling firm
Fresenius Kabi USA, Lake Zurich, IL
Manufacturer
Fresenius Kabi USA, LLC
Classification
Class II
Status
Terminated
Recall initiated
27 Sep 2012
FDA classified
10 Dec 2014
Reported
17 Dec 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Particulate Matter

Timeline

27 Sep 2012Recall initiated by company
10 Dec 2014Classified by FDA+804 days
17 Dec 2014Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.

Product as listed by the FDA

CYANOCOBALAMIN INJECTION, USP, 1000 mcg/mL, For IM or IV Use, Multiple Dose 2 mL Vials, Rx only. APP Pharmaceuticals, LLC, Schaumburg, IL 60173. NDC: 63323-044-01.

Where it was distributed

U.S. Nationwide Including Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.

Which lots are affected?

Lot 6003853, exp. date 04/2014

Where was it sold?

U.S. Nationwide Including Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 63451

More recalls from Fresenius Kabi USA

All 94

Other Cyanocobalamin recalls

All 23